Memantine Hydrochloride Tablet
Product Images NDC 50090-7356

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Memantine Hydrochloride (NDC 50090-7356). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl500907356)

FDA Label Image

Memantinetabs-figure6 (Memantinetabs Figure6)

This appears to be a section showing the Cumulative Percentage of Patients with a graph displaying data related to the change in ADCS-ADL from baseline. The data includes different medications such as Receho/Donepezil and Memastine Hydrochloride Tablets/Donepezil.*

FDA Label Image

Memantinetabscamberlogo (Memantinetabscamberlogo)

FDA Label Image

Memantinetabsfigure1 (Memantinetabsfigure1)

FDA Label Image

Memantinetabsfigure2 (Memantinetabsfigure2)

FDA Label Image

Memantinetabsfigure3 (Memantinetabsfigure3)

Mean change from baseline in SIB score over weeks of treatment with K Wt 5 tablets, showing clinical improvement. SEM is included.*

FDA Label Image

Memantinetabsfigure4 (Memantinetabsfigure4)

FDA Label Image

Memantinetabsfigure5 (Memantinetabsfigure5)

FDA Label Image

Memantinetabsfigure7 (Memantinetabsfigure7)

Mean (x SEM) Change from Baseline in Clinical Improvement with Memantine Hydrochloride Tablets/Donepezil over Weeks of Treatment.*

FDA Label Image

Memantinetabsfigure8 (Memantinetabsfigure8)

FDA Label Image

Memantinetabsstructure (Memantinetabsstructure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.